Susvimo, also known as ranibizumab injection, was first approved by the FDA for the treatment of wet age-related macular degeneration in 2021.

Wet age-related macular degeneration (wet AMD) is an eye condition caused by an altered production ... The high cost of the drug and the need for repeated injections into the eye put a big burden on ...

Subjects treated with the injection ... August 2021, Regeneron reported that an 8mg dose of aflibercept met the primary safety goal in a Phase II trial for wet age-related macular degeneration ...

South Korea — Korean scientists have developed a revolutionary eye drop treatment for dry age-related macular degeneration (AMD), potentially eliminating the need for regular eye injections that ...

In 2003 his right eye developed wet age-related macular degeneration ... Each month for 2 years Verle received an injection directly into his eye—and miraculously his vision slowly returned.

Although age is the top risk factor for age-related macular degeneration ... variants linked to a higher risk of developing AMD. A 2021 study using GWAS identified genetic variant combinations ...